Prevalence and Clinical Significance of Occult Pulmonary Infection in Elderly Patients with Type 2 Diabetes Mellitus

Hua, Jian; Huang, Ping; Liao, Honghui; Lai, Xiaobing; Zheng, Xiaoyi

doi:https://doi.org/10.1155/2021/3187388

BioMed Research International

On this page

Abstract Introduction Discussion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Lung Dysbiosis in Airway Diseases

View this Special Issue

Research Article | Open Access

Volume 2021 | Article ID 3187388 | https://doi.org/10.1155/2021/3187388

Prevalence and Clinical Significance of Occult Pulmonary Infection in Elderly Patients with Type 2 Diabetes Mellitus

Jian Hua,^1,2Ping Huang ,²Honghui Liao,¹Xiaobing Lai,¹and Xiaoyi Zheng¹

Academic Editor: Wen Ying Yu

Received25 Aug 2021

Accepted09 Nov 2021

Published02 Dec 2021

Abstract

The occult pulmonary infection is the most common complications in elderly patients with type 2 diabetes mellitus (T2DM). Since its etiological characteristics has not been clarified, infection control remains a serious problem for public health. To investigate the prevalence and clinical significance of occult pulmonary infection in elderly T2DM patients, in this study, 573 elderly patients cochallenged with T2DM and community-acquired pulmonary infection from January 2018 to December 2020 were selected in the hospitals and divided into occult pneumonia group (OP, ) and nonoccult pneumonia group (NOP, ) according to the nature of infection. Clinical medical records were analyzed retrospectively to summarize the infection characteristics of elderly diabetics with occult pneumonia. The prevalence of the cases (278/324, 85.8%) in NOP group was not higher than that in OP group (206/249, 82.7%; ). Also, there was not significant difference in the distribution of isolated pathogens among the positive patients. The length of hospitalization and mortality of OP patients were significantly higher than those NOP patients. Multivariate logistic regression showed that advanced age, comorbidities, hypothyroidism, senile dementia, and prolonged bed rest were independent risk factors for occult pneumonia in elderly diabetic patients. Therefore, the results demonstrated that the pulmonary infection in elderly patients with diabetes mellitus is often occult. Gram-negative bacteria are the predominant pathogens and cause poor prognosis. Advanced age, comorbidities (senile dementia, hypothyroidism), and prolonged bed rest are the independent risk factors for occult pneumonia.

1. Introduction

Diabetes mellitus is an endocrine and metabolic disease with high incidence and genetic tendency, which seriously affects the quality of life of patients and their offspring [1]. In the 1980s, the incidence of diabetes mellitus in China was only 1%. Nowadays, diabetics in China account for about 1/5 of the world’s total. More than 90% of the diabetic patients in China suffer from type 2 diabetes mellitus (T2DM), and the incidence is increasing year by year [2]. Early onset of T2DM is hidden and hard to cure after onset, which brings heavy financial burden to families and society [3–5]. At present, the specific pathogenesis of T2DM is not clear. It is generally believed to be caused by the interaction of various factors such as obesity, abnormal glucose and lipid metabolism, and inflammatory reactions [6–9].

Clinical trials showed that the incidence of pulmonary infection in patients with T2DM was significantly higher than that in nondiabetic patients, and the older the patient is, the greater the vascular fragility, with poor blood glucose control, deterioration of immune function, and a higher risk of pulmonary infections [10–12]. Occult pulmonary infection, which is more common in elderly patients, is a kind of pulmonary infection with no obvious respiratory symptoms [13–15]. It is difficult to determine the location of lesion and make initial diagnosis. At present, scholars do not have a precise definition and diagnostic criteria for occult pulmonary infection, but most elderly patients have multiple underlying diseases. Pulmonary infection with atypical clinical symptoms may lead to missed diagnosis, misdiagnosis, neglect of the disease, and missing the optimal opportunity for treatment, which may result in malignant progress of the disease and even endanger lives of patients [16]. Thus, it should be paid more attention. At present, the research on occult pulmonary infection is still in its infancy at home and abroad. Understanding the clinical status and risk factors of occult pulmonary infection in elderly patients with T2DM is of great clinical significance for controlling infection and improving the prognosis of patients. In this study, the case data of elderly patients with T2DM complicated with community-acquired pulmonary infection were retrospectively analyzed; the clinical etiological characteristics, treatment, and prognosis of such patients were summarized; and their risk factors were preliminarily analyzed to provide reference for clinical intervention.

2. Method

2.1. Study Population and Definitions

Totally, 573 elderly patients with T2DM complicated with community-acquired pulmonary infection treated in the second affiliated hospital of Zhejiang Chinese Medical University from January 2018 to December 2020 were selected. Inclusion criteria were employed as follows: (1) meeting diagnostic criteria of T2DM [17]; (2) meeting diagnostic criteria for community-acquired pulmonary infection [18]; (3) ; (4) hospital stay ≥3 days; and (5) clinical data fully available. Exclusion criteria: (1) complicated with infection of other sites; (2) changes in leukocyte level caused by other noninfectious diseases; (3) presence of immune system disorders; (4) antimicrobial drugs taken before the first collection of pathogenic specimens; (5) complicated with other chronic pulmonary diseases. The patients were divided into occult pneumonia group and nonoccult pneumonia group according to whether the pulmonary infection is occult or not. Diagnostic criteria for occult pneumonia were employed as follows: (1) no typical respiratory symptoms, including cough, sputum, and chest pain; (2) diagnosis confirmed by computed tomography (CT); (3) patients with no obvious abnormalities in CT and unable to complete CT examination, positive sputum culture or blood culture, and elevated inflammatory indicators are effective after empirical anti-infective therapy. Also, the indexes of blood routine, urine routine, and hepatic and renal function were examined to exclude vasculitis, and the throat swabs were detected by RT-PCR analysis to exclude various acute infection including COVID-19. The flow chart of the study protocol and diagnostic work up was presented in Figure 1. This study has been approved by the ethics committee of the second affiliated hospital of Zhejiang Chinese Medical University.

2.2. Clinical Information

Clinical data of patients were collected, including age, gender, living habits (smoking history, drinking history), underlying diseases (hypertension, coronary disease, senile dementia, etc.), hypothyroidism, invasive operations (invasive airway operation and indwelling catheter), nasal feeding, long-term bed rest, glucocorticoid use, results of etiology and drug sensitivity analysis, length of hospital stay, and mortality. The biochemical indicators, such as white blood cell (WBC), procalcitonin (PCT), and albumin (ALB), were detected by automatic biochemical analyzer (HITACHI 7180, Japan) in the serum. Sputum samples were collected from the patients at the second affiliated hospital of Zhejiang Chinese Medical University and cultured in blood agar media for the microbiological and genomic analysis. Positive cultures with colonies suspected of lethal pathogens and resistant bacteria were sent to the laboratory of microbiology of hospital for further DNA extraction.

2.3. Statistical Analysis

GraphPad Prism 9 (GraphPad Software, San Diego, USA) was used for data processing and analysis. Measurement data were presented as . Comparisons were by -test. Enumeration data were presented in rate (%). Comparisons were made by -test. The risk factors of occult pneumonia in elderly diabetic patients were analyzed by logistic regression. was taken as statistically significant.

3. Result

3.1. Clinical Characteristics

After a detailed assessment according to the inclusion and exclusion criteria, a total of 573 subjects were considered in the analysis. Their mean age was , and male patients were 53.6%. A history of smoking was present in 33.0% and drinking in 14.5%. All the patients had basic diseases, in which 16.8% had two more basic diseases.

3.2. Clinical Characteristics of Pulmonary Infection in T2DM Patients

The distribution of pathogenic bacteria detected in the two groups was shown in Table 1. Totally, 206 induced sputum samples were positive to the pathogenic bacteria culture in 249 patients of the occult group (OP), whose positive rate was 82.7%, and 157 kinds of pathogenic bacteria were detected among 249 OP samples. In other hand, 278 samples were positive in 324 patients of the nonoccult group (NOP), whose positive rate was 85.8%, and 183 kinds of pathogenic bacteria were detected. However, there was no significantly difference in the positive rate of pathogen culture between the two groups (, ). Although the components of pathogens detected in positive patients were not identical, there was no significantly difference in the distribution of pathogens detected in positive patients (, ).

3.3. Treatment and Prognosis of Pulmonary Infection in T2DM Patients

All patients received conventional treatments, such as blood glucose reduction, anti-infection, and nutritional replenishment. The empirical anti-infection treatment was employed by mainly using antimicrobial drugs such as carbapenems and β lactam/enzyme inhibitors. When the condition did not improve, sensitive drugs were selected according to the results of drug sensitivity. Imipenem and vancomycin were used cautiously in patients with resistance changes. In the contrast of the prognosis of the two groups as shown in Table 2, patients in the occult group had a higher length of hospital stay and case fatality rate than those in the nonoccult group ().

3.4. Univariate Analysis of Occult Pneumonia in T2DM Patients

As shown in Table 3, the results by using univariate analysis presented that there were significantly differences in age, senile dementia, hypothyroidism, WBC, PCT, C-reactive protein (CRP), and prolonged bed rest between the two groups (). It indicated that those indexes could contribute to the development and outcome of the occult pneumonia in T2DM patients.

3.5. Multivariate Analysis of Occult Pneumonia in T2DM Patients

As showed in Table 4, the results obtained from multivariate logistic regression analysis presented that advanced age, senile dementia, hypothyroidism, and prolonged bed rest were independent risk factors for occult pneumonia in elderly diabetic patients (), whose OR values were all more than 1, and values were less than 0.05, indicating the statistical significance.

4. Discussion

Numerous studies have confirmed that diabetes is an important risk factor for pulmonary infection. Several reasons have been found: (1) high blood glucose levels provide good growth conditions for pathogenic bacteria, which facilitates their mass multiplication; (2) hyperglycemia increases plasma osmotic pressure and attenuates the chemotaxis, phagocytosis, and bactericidal ability of neutrophils, resulting in decreased clearance of pulmonary pathogens; (3) hyperglycemia can reduce cellular immunity and the body’s anti-infective ability, increasing the risk of infection; (4) diabetes mellitus is often associated with uremia, ketoacidosis, and other complications. The patients have metabolic disorders, negative nitrogen balance, and a higher probability of infection. And in patients with vasculopathy, reduced tissue blood flow also reduces the absorption of antibiotics [19–22]. Occult pneumonia refers to insidious clinical symptoms and/or insidious lesion sites, which are not easily diagnosed at the initial diagnosis, often without typical symptoms of respiratory tract infection such as cough, sputum, and chest pain, and are mostly seen in the elderly population. At present, there are few clinical studies on occult pneumonia, and there are no accepted definitions and diagnostic criteria. According to the previous reports, elderly patients were the high-risk population of occult pulmonary infection. Elderly patients have a substantially increased risk of pulmonary infection since all physiological functions of the body were in an attenuated state, and their typical respiratory symptoms were very easily masked by underlying diseases. When the pulmonary infection overlaps with the sagittal position of the heart or spine, chest X-ray (CXR) often fails to confirm the diagnosis, resulting in misdiagnosis or delay in anti-infective treatment and even multiorgan dysfunction, thus endangering patient’s life [11, 23–25]. Therefore, understanding the clinical manifestations and risk factors of occult pulmonary infections in elderly diabetic patients is important for controlling infections and improving prognosis.

In this study, the predominant pathogens of elderly patients with occult pulmonary infection and nonoccult pulmonary infection were all Gram-negative bacteria, marked by Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. The results were basically consistent with previous reports, and the inconsistency in specific proportions might be related to different geographical environments [12, 26]. Moreover, patients in both groups were treated with comprehensive treatment, and the treatment was basically similar. After the diagnosis of pulmonary infection in elderly patients, it is necessary to carefully assess the severity of the disease with reference to the physiological characteristics of the elderly population and select sensitive antibiotics to control the infection. Prompt drug replacement is necessary in case of resistance changes in the causative organism. For patients who are receiving many antibiotics and invasive procedures, the possibility of drug-resistant strains should be considered. Patients with long-term medication and malnutrition should be cautioned against the occurrence of superinfection. In addition, patients in the occult group had longer hospital stays and a higher case fatality rate, suggesting that the prognosis of elderly patients with diabetes mellitus complicated with occult pulmonary infection was worse.

It has been known that the patients with T2DM are prone to pneumonia for a variety of reasons, including impairment of immune function, impairment of pulmonary function, and ischemia-hypoxia due to hyperglycemia-induced collage synthesis decrease and secondary vascular endothelial changes [11]. In elderly patients with severe pneumonia, fasting glucose values ≥11 mmol/L and glycosylated hemoglobin >7% were significantly and positively associated with increased risk of death. High glycosylated hemoglobin was an independent risk factor for increased mortality risk [12, 27]. However, oral antidiabetic drugs have been demonstrated to be associated with community-acquired pneumonia [28]. Notably, any combination with thiazolidinediones and other antidiabetic drugs had been considered to increase higher risk of community-acquired pneumonia, while the use of DPP-4 inhibitors or metformin dose not display this danger [29–32].

We also found that the risk factors of occult pulmonary infection in elderly patients with T2DM were analyzed. The results showed that age, senile dementia, hypothyroidism, WBC, PCT, ALB, and prolonged bed rest were related to occult pulmonary infection, and that advanced age, senile dementia, hypothyroidism, and prolonged bed rest were independent risk factors for occult pneumonia. Patients of advanced age have a low capacity to respond to stress. This was because mass neutrophils remain in the viscera and the adhesion of neutrophils was enhanced after infection. Their peripheral blood levels were not increased but decreased. The body temperature might also decrease or remain normal. More cough reflex inhibition made the cough symptoms mild or without cough. The onset was insidious due to lack of fever, cough, and other typical clinical symptoms [33]. For patients with senile dementia, the brainstem had poor regulation of respiratory function, and the lungs had a greatly diminished ability to clear pathogens, which, combined with the fact that they often present with language impairment and had difficulty expressing subjective sensation, thereby delaying the treatment [34]. Studies have shown that multiple neuroendocrine hormone abnormalities are present in patients with diabetes mellitus, manifested by glucocorticoid hypersecretion and dysfunction of hypothalamo-hypophyseal-thyroidal axis (HHTA) [35–37]. Moreover, with increasing age, HHTA also becomes progressively aged, leading to hypothyroidism manifested by reduced respiration, hypothermia, and hyporeflexia, which can mask infectious symptoms and lead to occult pulmonary infections [38–40]. In addition, long-term bed ridden patients have relatively elevated diaphragmatic position, and the scope of their imaging ghosting is enlarged, making it difficult to obtain good and comprehensive evidence from chest X-ray imaging. Therefore, the infection could be easily concealed.

In summary, the pulmonary infections in elderly patients with diabetes mellitus are often occult. The predominant pathogens are Gram-negative bacteria. The prognosis is poor. Advanced age, comorbidities (senile dementia, hypothyroidism), and prolonged bed rest are the independent risk factors for occult pneumonia. Clinical attention should be paid to the following points for such elderly patients: (1) improve lung CT examination and laboratory inflammatory indicator test as soon as possible to raise the detection rate of occult pulmonary infection; (2) aggressively give anti-infective treatment after the diagnosis of occult pulmonary infection; select sensitive antibiotics and adjust medication regimen in a timely manner according to treatment effect; (3) aggressively treat the underlying diseases of elderly patients, especially those with senile dementia and hypothyroidism, to avoid occult pulmonary infections. However, this study is a retrospective study with a low level of evidence. Future efforts will be made to carry out prospective, multicenter, and large-sample studies to further analyze the status of occult pulmonary infections in elderly patients with endocrine diseases.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no conflict of interests.

Acknowledgments

This work is supported by the Famous Traditional Chinese Medicine Expert Inheritance Studio of Ping Huang (no. GZS2020024).

References

M. G. Tinajero and V. S. Malik, “An update on the epidemiology of type 2 diabetes: a global perspective,” Endocrinology and Metabolism Clinics of North America, vol. 50, no. 3, pp. 337–355, 2021.
View at: Publisher Site | Google Scholar
J. Fu and H. C. Prasad, “Changing epidemiology of metabolic syndrome and type 2 diabetes in Chinese youth,” Current Diabetes Reports, vol. 14, no. 1, p. 447, 2014.
View at: Publisher Site | Google Scholar
J. Leal, D. Ahrabian, M. J. Davies et al., “Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the let's prevent diabetes cluster-randomised controlled trial,” BMJ Open, vol. 7, no. 1, article e013592, 2017.
View at: Publisher Site | Google Scholar
T. Nerat, I. Locatelli, and M. Kos, “Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventions,” Patient Preference and Adherence, vol. Volume 10, pp. 2039–2049, 2016.
View at: Publisher Site | Google Scholar
E. Buttermore, V. Campanella, and R. Priefer, “The increasing trend of type 2 diabetes in youth: an overview,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 15, no. 5, article 102253, 2021.
View at: Publisher Site | Google Scholar
S. Demir, P. P. Nawroth, S. Herzig, and B. Ekim Üstünel, “Emerging targets in type 2 diabetes and diabetic complications,” Advanced Science, vol. 8, no. 18, article e2100275, 2021.
View at: Publisher Site | Google Scholar
T. Vezza, A. M. de Marañón, F. Canet et al., “MicroRNAs and oxidative stress: an intriguing crosstalk to be exploited in the management of type 2 diabetes,” Antioxidants, vol. 10, no. 5, p. 802, 2021.
View at: Publisher Site | Google Scholar
S. H. Shahcheraghi, A. A. A. Aljabali, M. S. Al Zoubi et al., “Overview of key molecular and pharmacological targets for diabetes and associated diseases,” Life Sciences, vol. 278, no. 278, article 119632, 2021.
View at: Publisher Site | Google Scholar
S. A. Dabravolski, V. A. Orekhova, M. S. Baig et al., “The role of mitochondrial mutations and chronic inflammation in diabetes,” International Journal of Molecular Sciences, vol. 22, no. 13, p. 6733, 2021.
View at: Publisher Site | Google Scholar
D. Visca, P. Pignatti, A. Spanevello, E. Lucini, and E. La Rocca, “Relationship between diabetes and respiratory diseases--Clinical and therapeutic aspects,” Pharmacological Research, vol. 137, pp. 230–235, 2018.
View at: Publisher Site | Google Scholar
V. C. Brunetti, H. T. Ayele, O. H. Y. Yu, P. Ernst, and K. B. Filion, “Type 2 diabetes mellitus and risk of community-acquired pneumonia: a systematic review and meta-analysis of observational studies,” CMAJ Open, vol. 9, no. 1, pp. E62–E70, 2021.
View at: Publisher Site | Google Scholar
S. Cheng, G. Hou, Z. Liu et al., “Risk prediction of in-hospital mortality among patients with type 2 diabetes mellitus and concomitant community-acquired pneumonia,” Annals of Palliative Medicine, vol. 9, no. 5, pp. 3313–3325, 2020.
View at: Publisher Site | Google Scholar
M. Pichon, M. Micaelo, S. Rasoanandrasana, and A. M. Menn, “Molecular characterization ofStaphylococcus aureusisolates derived from severe pneumonia: a retrospective monocentre study,” Infectious Diseases, vol. 53, no. 11, pp. 811–819, 2021.
View at: Publisher Site | Google Scholar
J. Nambafu, M. Achakolong, F. Mwendwa et al., “A prospective observational study of community acquired pneumonia in Kenya: the role of viral pathogens,” BMC Infectious Diseases, vol. 21, no. 1, p. 703, 2021.
View at: Publisher Site | Google Scholar
S. Du, X. Wu, B. Li et al., “Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia,” Frontiers in Medicine, vol. 24, pp. 1–14, 2021.
View at: Publisher Site | Google Scholar
W. Shi, M. Duan, L. Jie, and W. Sun, “A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome,” Medicine (Baltimore), vol. 97, no. 19, article e0595, 2018.
View at: Publisher Site | Google Scholar
R. M. M. Khan, Z. J. Y. Chua, J. C. Tan, Y. Yang, Z. Liao, and Y. Zhao, “From pre-diabetes to diabetes: diagnosis, treatments and translational research,” Medicina (Kaunas, Lithuania), vol. 55, no. 9, p. 546, 2019.
View at: Publisher Site | Google Scholar
A. Torres, J. D. Chalmers, C. S. Dela Cruz et al., “Challenges in severe community-acquired pneumonia: a point-of-view review,” Intensive Care Medicine, vol. 45, no. 2, pp. 159–171, 2019.
View at: Publisher Site | Google Scholar
R. Unnikrishnan and A. Misra, “Infections and diabetes: risks and mitigation with reference to India,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 14, no. 6, pp. 1889–1894, 2020.
View at: Publisher Site | Google Scholar
A. Atreja and S. Kalra, “Infections in diabetes,” The Journal of the Pakistan Medical Association, vol. 65, no. 9, pp. 1028–1030, 2015.
View at: Google Scholar
C. Molinari, A. Laurenzi, A. Caretto et al., “Dysglycemia after COVID-19 pneumonia: a six-month cohort study,” Acta Diabetologica, vol. 4, pp. 1–10, 2021.
View at: Google Scholar
K. M. Nada, S. Nishi, and A. Duarte, “Pneumonia and poorly controlled diabetes,” Chest, vol. 159, no. 5, pp. e343–e347, 2021.
View at: Publisher Site | Google Scholar
C. D. Furman, A. Leinenbach, R. Usher, J. Elikkottil, and F. W. Arnold, “Pneumonia in older adults,” Current Opinion in Infectious Diseases, vol. 34, no. 2, pp. 135–141, 2021.
View at: Publisher Site | Google Scholar
J. Huang, Y. Xie, D. Yuan, L. Guo, J. Qu, and M. Zhou, “Identification of distinct metabolic characteristics of pneumonia in type 2 diabetes mellitus,” Clinical and Translational Medicine, vol. 11, no. 2, article e303, 2021.
View at: Publisher Site | Google Scholar
P. M. Lepper, R. Bals, P. Jüni, and M. von Eynatten, “Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia,” Diabetologia, vol. 63, no. 11, pp. 2488–2490, 2020.
View at: Publisher Site | Google Scholar
X. Li, X. Qi, G. Yuan et al., “Microbiological profile and clinical characteristics of diabetic foot infection in northern China: a retrospective multicentre survey in the Beijing area,” Journal of Medical Microbiology, vol. 67, no. 2, pp. 160–168, 2018.
View at: Publisher Site | Google Scholar
Y. Zhao, Y. Liu, F. Yi et al., “Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients,” International Immunopharmacology, vol. 93, article 107406, 2021.
View at: Publisher Site | Google Scholar
L. C. Saiz, J. Garjón, J. Gorricho, J. Erviti, M. J. Gil-García, and E. Martín-Merino, “Validation and incidence of community-acquired pneumonia in patients with type 2 diabetes in the BIFAP database,” Epidemiology and Infection, vol. 145, no. 14, pp. 3056–3064, 2017.
View at: Publisher Site | Google Scholar
J. Gorricho, J. Garjón, A. Alonso et al., “Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study,” British Journal of Clinical Pharmacology, vol. 83, no. 9, pp. 2034–2044, 2017.
View at: Publisher Site | Google Scholar
J. L. Faillie, K. B. Filion, V. Patenaude, P. Ernst, and L. Azoulay, “Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes,” Diabetes, Obesity & Metabolism, vol. 17, no. 4, pp. 379–385, 2015.
View at: Publisher Site | Google Scholar
D. Nabrdalik-Leśniak, K. Nabrdalik, K. Sedlaczek et al., “Influence of SGLT2 inhibitor treatment on urine antioxidant status in type 2 diabetic patients: a pilot study,” Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 5593589, 10 pages, 2021.
View at: Publisher Site | Google Scholar
M. M. Cojic, A. Klisic, R. Kocic, A. Veljkovic, and G. Kocic, “Data-driven cluster analysis of oxidative stress indexes in relation to vitamin D level, age, and metabolic control in patients with type 2 diabetes on metformin therapy,” Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 7942716, 11 pages, 2021.
View at: Publisher Site | Google Scholar
C. Feldman and E. Shaddock, “Epidemiology of lower respiratory tract infections in adults,” Expert Review of Respiratory Medicine, vol. 13, no. 1, pp. 63–77, 2019.
View at: Publisher Site | Google Scholar
O. Henig and K. S. Kaye, “Bacterial pneumonia in older adults,” Infectious Disease Clinics of North America, vol. 31, no. 4, pp. 689–713, 2017.
View at: Publisher Site | Google Scholar
S. Barsiah, M. Behnam-Rassouli, F. Shahabipour et al., “Evaluation of testis hormonal and histopathological alterations in type I and type II diabetic rats,” Journal of Cellular Biochemistry, vol. 120, no. 10, pp. 16775–16785, 2019.
View at: Publisher Site | Google Scholar
M. Obulkasim, A. Turdi, N. Amat et al., “Neuroendocrine-immune disorder in type 2 diabetic patients with retinopathy,” Clinical and Experimental Pharmacology & Physiology, vol. 38, no. 4, pp. 229–232, 2011.
View at: Publisher Site | Google Scholar
R. Subba, R. Sandhir, S. P. Singh, B. N. Mallick, and A. C. Mondal, “Pathophysiology linking depression and type 2 diabetes: psychotherapy, physical exercise, and fecal microbiome transplantation as damage control,” The European Journal of Neuroscience, vol. 53, no. 8, pp. 2870–2900, 2021.
View at: Publisher Site | Google Scholar
N. Miyashita and Y. Yamauchi, “Bacterial pneumonia in elderly Japanese populations,” Japanese Clinical Medicine, vol. 9, no. 9, article 1179670717751433, 2018.
View at: Publisher Site | Google Scholar
M. J. Mangen, S. M. Huijts, M. J. Bonten, and G. A. de Wit, “The impact of community-acquired pneumonia on the health-related quality-of-life in elderly,” BMC Infectious Diseases, vol. 17, no. 1, p. 208, 2017.
View at: Publisher Site | Google Scholar
H. Çelikhisar, G. Daşdemir Ilkhan, and Ç. Arabaci, “Prognostic factors in elderly patients admitted to the intensive care unit with community-acquired pneumonia,” The Aging Male, vol. 23, no. 5, pp. 1425–1431, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Jian Hua et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

475

Downloads

821

Citations